PerpEquities

Equity

Is Ecolab (ECL) tradable as a perp? Not yet

Ecolab provides water, hygiene, and infection prevention solutions across water treatment, institutional cleaning, pest elimination, and life sciences segments.

Not yet listed on any perp exchange

No perpetual-futures venue lists ECL yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
AEMFCXZIJINMININGAPDSHINETSUB

Price chart

Interactive TradingView chart

TradingView symbol NYSE:ECL

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-29 · next report 2027-02-09 · Updated 125h ago
All financials →

Valuation & key figures

Market cap
$84.9B
Updated 125h ago
Revenue
$17.4B
Trailing 12 months
Revenue growth
+11%
Next fiscal year
Profit margin
+12.0%
P/E
40.9
Peer P/E 15.5
P/S
4.9
Peer P/E
15.5
Similar listed perps
Free cash flow
$1.8B
Trailing 12 months
Net income
$2.1B
Trailing 12 months
Revenue estimate
$17.9B
Next fiscal year
Earnings
2027-02-09
Revenue est. $4.8B · Updated 125h ago
Dividend
$0.73
2026-09-15
Revenue (TTM)$17.4B+9.3% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)17.1%-0.1 pp vs a year agoOperating income $2.98B
Net income (TTM)$2.08B+4.9% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$1.8B+15.6% vs a year agoCapex $1.23B
Diluted EPS (TTM)$7.35+5.6% vs a year agoSum of the last 4 quarters
Net cash-$13B-74.6% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-27): revenue in line, EPS in lineRevenue $4.69B vs $4.7B expected (-0.1%); EPS $2.18 vs $2.18 (0.0%).
  • Revenue growth accelerating: 12.7% year on yearQ3 '26 revenue $4.69B, against an average of 7.2% over the four quarters before.
  • Operating margin 17.1% (TTM), -0.1 pp on a year agoOperating income grew 8.5% while revenue grew 9.3%.
  • 14.2% of pre-tax profit is eaten by non-operating lossesPre-tax income $2.61B vs operating income $2.98B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Segments in Q3 '26

from the filing
SegmentRevenuey/yOp. incomeMargin
Water Services$2.48B+20.7%$445M17.9%
Global Institutional$1.64B+2.7%$405M24.7%
Global Pest Elimination$364M+9.6%$73.9M20.3%
Global Healthcare And Life Sciences$214M+15.8%$50.2M23.5%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 296 lines Ecolab Inc. reported to the SEC

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20268.16$17.9B+11%14
FY 20279.40$19.3B+20%15
FY 202810.74$20.6B+28%6
Q1 20271.89$4.5B+11%8
Q2 20272.31$4.9B+10%4
Q3 20272.56$5B+6%3

Company events

6
2027-02-09EarningsActual - / Estimate 2.2-
2026-10-27Earnings · Before market openActual 2.18 / Estimate 2.18In line
2026-09-15Dividend$0.73-
2026-07-28EarningsActual 2.09 / Estimate 2.08Beat
2026-06-16Dividend$0.73-
2026-04-28EarningsActual 1.7 / Estimate 1.7In line

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
AEM$83.6B5.613.6+41.0%1FCX$89.8B3.426.2+13.0%5ZIJINMINING$94.1B1.710.2+18.9%1APD$71B5.6-1,533.0-0.4%5SHINETSU$68.6B4.022.0+18.6%1B$66B3.210.4+31.6%1NUE$62.1B1.617.4+9.3%1WPM$59.7B18.829.1+64.7%1

Analyst track record

How the analysts covering ECL have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings141385
Analysts2433
Buy / hold / sell120 / 21 / 0282 / 101 / 2
Upgrades / downgrades / initiations8 / 1 / 020 / 5 / 6
Price targets hit / missed38 / 78 (33%)212 / 121 (64%)
Avg. return after a rating (TipRanks)-5.2%+6.6%
Best / worst call+15.7% / -16.4%+67.1% / -16.4%

After buy calls on this stock: median 21-day move +2.1% vs S&P 500 -1.0% (n = 274)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Vincent AndrewsMorgan Stanley100% hit rate on this stock · 8 targets measuredBuytarget $330Oct 27, 2026
  2. Manav PatnaikBarclays93% hit rate on this stock · 27 targets measuredBuytarget $300Oct 26, 2026
  3. Ashish SabadraRBC Capital85% hit rate on this stock · 27 targets measuredBuytarget $337Oct 14, 2026

Latest ratings

DateAnalystCallTarget
Oct 27, 2026John McNultyBMO CapitalBuyMaintained$360article ↗
Oct 28, 2026Scott SchneebergerOppenheimerBuyMaintained$320article ↗
Oct 28, 2026Joshua SpectorUBSBuyReiterated$357article ↗
Oct 28, 2026Jeffrey ZekauskasJ.P. MorganBuyReiterated$310article ↗
Oct 28, 2026Jeffrey ZekauskasJ.P. MorganBuyMaintained$310article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$260$280$300$320Dec 25 · Buy 14 · Hold 6 · Sell 0Dec 25Jan 26 · Buy 14 · Hold 7 · Sell 0Feb 26 · Buy 14 · Hold 6 · Sell 0Feb 26Mar 26 · Buy 16 · Hold 6 · Sell 0Apr 26 · Buy 17 · Hold 5 · Sell 0Apr 26May 26 · Buy 17 · Hold 5 · Sell 0Jun 26 · Buy 17 · Hold 5 · Sell 0Jun 26Jul 26 · Buy 19 · Hold 3 · Sell 0Aug 26 · Buy 19 · Hold 3 · Sell 0Aug 26Sep 26 · Buy 18 · Hold 2 · Sell 0Oct 26 · Buy 17 · Hold 2 · Sell 0Oct 26Nov 26 · Buy 17 · Hold 2 · Sell 0Dec 25 · avg. target $298Jan 26 · avg. target $300Feb 26 · avg. target $325Mar 26 · avg. target $323Apr 26 · avg. target $317May 26 · avg. target $319Jun 26 · avg. target $320Jul 26 · avg. target $327Aug 26 · avg. target $323Sep 26 · avg. target $324Oct 26 · avg. target $329Nov 26 · avg. target $329Dec 25 · month-end close $263Jan 26 · month-end close $282Feb 26 · month-end close $308Mar 26 · month-end close $266Apr 26 · month-end close $261May 26 · month-end close $256Jun 26 · month-end close $279Jul 26 · month-end close $278Aug 26 · month-end close $283Sep 26 · month-end close $275Oct 26 · month-end close $303Nov 26 · month-end close $303

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Oct 30, 2026 · 141 ratings